Summary
Low-dose CT screening improves timely diagnosis of lung cancer and all-cause mortality. This commentary reviews the first five years of England’s national program, which invited more than two million people and diagnosed 7,193 lung cancers with an increase in early-stage diagnosis and improvements among high-risk and underserved groups. The report highlights large-scale implementation policies necessary to achieve such a a program.
Lee RW, Nair A, Balata H, et al. Implementation of the NHS England Lung Cancer Screening Programme over 5 years. Nat Med. 2026;32(5):1817-1826.